Literature DB >> 1538157

The natural history of cutaneous leishmaniasis in Guatemala.

B L Herwaldt1, B A Arana, T R Navin.   

Abstract

The natural history of American cutaneous leishmaniasis was studied in Guatemala by analyzing the characteristics of 355 untreated leishmanial lesions, observing the evolution of 57 lesions on persons who received a placebo in treatment trials, and analyzing data from a population-based survey concerning the duration of 82 untreated lesions. Of 25 lesions caused by Leishmania mexicana that were followed prospectively, 22 (88%) completely reepithelialized by a median lesion age of 14 weeks, and 17 (68%) were classified as cured (no residual wound inflammation or reactivation during at least 6 months of follow-up). In contrast, 7 (22%) of 32 lesions caused by Leishmania braziliensis reepithelialized by a median lesion age of 13 weeks, and only 2 (6%) cured. These data demonstrate that the species of Leishmania is the primary determinant of the clinical course and outcome of untreated lesions and underscore the need for field-applicable diagnostic techniques that provide rapid species identification.

Entities:  

Mesh:

Year:  1992        PMID: 1538157     DOI: 10.1093/infdis/165.3.518

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and Treatment.

Authors:  Jonathan Berman
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

2.  Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.

Authors:  Adrienne J Showler; Andrea K Boggild
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  Detection and identification of Leishmania spp.: application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World.

Authors:  Ana M Montalvo; Jorge Fraga; Dídier Tirado; Gustavo Blandón; Annia Alba; Gert Van der Auwera; Iván Darío Vélez; Carlos Muskus
Journal:  Parasitol Res       Date:  2017-06-01       Impact factor: 2.289

Review 4.  [Cutaneous leishmaniasis].

Authors:  C D Enk; K Gardlo; M Hochberg; A Ingber; T Ruzicka
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

5.  Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil.

Authors:  Alon Unger; Seth O'Neal; Paulo R L Machado; Luiz H Guimarães; Daniel J Morgan; Albert Schriefer; Olívia Bacellar; Marshall J Glesby; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

6.  Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization.

Authors:  N Rodríguez; B Guzman; A Rodas; H Takiff; B R Bloom; J Convit
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Cutaneous leishmaniasis control in Alta Verapaz (northern Guatemala): evaluating current efforts through stakeholders' experiences.

Authors:  Renata Mendizábal-Cabrera; Isabel Pérez; Víctor Becerril Montekio; Freddy Pérez; Erick Durán; Mei L Trueba
Journal:  Infect Dis Poverty       Date:  2021-05-07       Impact factor: 4.520

8.  Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.

Authors:  Piero Olliaro; Michel Vaillant; Byron Arana; Max Grogl; Farrokh Modabber; Alan Magill; Olivier Lapujade; Pierre Buffet; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2013-03-21

9.  Oral Tolerance Induced by Heat Shock Protein 65-Producing Lactococcus lactis Mitigates Inflammation in Leishmania braziliensis Infection.

Authors:  Priscila Valera Guerra; Camila Mattos Andrade; Ivanéia Valeriano Nunes; Brena Cardoso Gama; Rafael Tibúrcio; Washington Luis Conrado Santos; Vasco Ariston Azevedo; Natalia Machado Tavares; Juliana de Souza Rebouças; Tatiani Uceli Maiolii; Ana Maria Caetano Faria; Cláudia Ida Brodskyn
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

10.  Nodular lymphangitis: a distinctive clinical entity with finite etiologies.

Authors:  Mark J DiNubile
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.